All Stories

  1. Successful Pregnancies After Adequate Hormonal Replacement in Patients With Combined Pituitary Hormone Deficiencies
  2. Paternally Inherited DLK1 Deletion Associated With Familial Central Precocious Puberty
  3. Expression of LIN28 and its regulatory microRNAs in adult adrenocortical cancer
  4. Autosomal recessive form of isolated growth hormone deficiency is more frequent than the autosomal dominant form in a Brazilian cohort
  5. Role of gonadotropin-releasing hormone receptor mutations in patients with a wide spectrum of pubertal delay
  6. Quality of life in a large cohort of adult Brazilian patients with 46,XX and 46,XY disorders of sex development from a single tertiary centre
  7. Genetic Predictors of Long-Term Response to Growth Hormone (GH) Therapy in Children With GH Deficiency and Turner Syndrome: The Influence of a SOCS2 Polymorphism
  8. Quality of life of patients with 46,XX and 46,XY disorders of sex development
  9. ARMC5Mutations Are a Frequent Cause of Primary Macronodular Adrenal Hyperplasia
  10. Central Precocious Puberty That Appears to Be Sporadic Caused by Paternally Inherited Mutations in the Imprinted Gene Makorin Ring Finger 3
  11. Increased expression of ACTH (MC2R) and androgen (AR) receptors in giant bilateral myelolipomas from patients with congenital adrenal hyperplasia
  12. Long-Term Followup of a Large Cohort of Patients with Ovotesticular Disorder of Sex Development
  13. Análise de um radioimunoensaio iodado para determinação de 11-deoxicortisol
  14. Clinical management of transsexual subjects
  15. Avanços na etiologia, no diagnóstico e no tratamento da puberdade precoce central
  16. Atividades Musicais Interativas como Instrumento Humanizador para Redução do Estresse de Crianças Submetidas a Cirurgias Urológicas.
  17. 46,XY DSD due to 17β-Hydroxysteroid Dehydrogenase 3 Deficiency
  18. Amplification of theInsulin-Like Growth Factor 1 ReceptorGene Is a Rare Event in Adrenocortical Adenocarcinomas: Searching for Potential Mechanisms of Overexpression
  19. Influence of the A3669G Glucocorticoid Receptor Gene Polymorphism on the Metabolic Profile of Pediatric Patients with Congenital Adrenal Hyperplasia
  20. Homozygous Inactivating Mutation inNANOS3in Two Sisters with Primary Ovarian Insufficiency
  21. Combined use of multiplex ligation-dependent probe amplification and automatic sequencing for identification of KAL1 defects in patients with Kallmann syndrome
  22. 103 TRANSSEXUAL GENITAL SURGERY: COMPLICATIONS AND FUNCTIONAL RESULTS AFTER 13 YEARS OF EXPERIENCE
  23. Relatively high frequency of non‐synonymous GLI2 variants in patients with congenital hypopituitarism without holoprosencephaly
  24. Analysis of the insulin‐like growth factor 1 receptor gene in children born small for gestational age: in vitro characterization of a novel mutation (p.Arg511Trp)
  25. Y chromosome aberration in a patient with cloacal-bladder exstrophy-epispadias complex: an unusual finding
  26. Obesity and Familial Predisposition Are Significant Determining Factors of an Adverse Metabolic Profile in Young Patients with Congenital Adrenal Hyperplasia
  27. The benign spectrum of hypothalamic hamartomas: Infrequent epilepsy and normal cognition in patients presenting with central precocious puberty
  28. Molecular and Gene Network Analysis of Thyroid Transcription Factor 1 <b><i>(TTF1)</i></b> and Enhanced at Puberty <b><i>(EAP1)</i></b> Genes in Patients with GnRH-Dependent Pubertal Disorders
  29. The Sitting Height/Height Ratio for Age in Healthy and Short Individuals and Its Potential Role in Selecting Short Children for <b><i>SHOX</i></b> Analysis
  30. Mutational analysis of TAC3 and TACR3 genes in patients with idiopathic central pubertal disorders
  31. Analysis of anti-Müllerian hormone (AMH) and its receptor (AMHR2) genes in patients with persistent Müllerian duct syndrome
  32. Novel mutation in the gonadotropin-releasing hormone receptor (GNRHR) gene in a patient with normosmic isolated hypogonadotropic hypogonadism
  33. Disorders of Sex Development
  34. DSD Due to 5α-Reductase 2 Deficiency - from Diagnosis to Long Term Outcome
  35. Advice on the Management of Ambiguous Genitalia to a Young Endocrinologist from Experienced Clinicians
  36. Impact of Glucocorticoid Receptor Gene Polymorphisms on the Metabolic Profile of Adult Patients with the Classical Form of 21-Hydroxylase Deficiency
  37. Growth standards of patients with Noonan and Noonan‐like syndromes with mutations in the RAS/MAPK pathway
  38. Laparoscopic adrenalectomy in children
  39. 1527 GONADAL TUMOR DETECTION AND TREATMENT IN PATIENTS WITH DISORDER OF SEX DEVELOPMENT (DSD) LONG-TERM ONCOLOGICAL OUTCOMES
  40. Potential Effects of Alendronate on Fibroblast Growth Factor 23 Levels and Effective Control of Hypercalciuria in an Adult with Jansen's Metaphyseal Chondrodysplasia
  41. The Interactive Effect ofGHR-Exon 3and −202 A/C IGFBP3Polymorphisms on rhGH Responsiveness and Treatment Outcomes in Patients with Turner Syndrome
  42. GH-Releasing Hormone Receptor Gene: A Novel Splice-Disrupting Mutation and Study of Founder Effects
  43. Absence of Functional <b><i>LIN28B</i></b> Mutations in a Large Cohort of Patients with Idiopathic Central Precocious Puberty
  44. Weight-adjusted neonatal 17OH-progesterone cutoff levels improve the efficiency of newborn screening for congenital adrenal hyperplasia
  45. 18F-FDG-PET/CT Imaging of ACTH-Independent Macronodular Adrenocortical Hyperplasia (AIMAH) Demonstrating Increased18F-FDG Uptake
  46. Catch-Up Growth in Patients with Congenital or Acquired Growth Hormone Deficiency After GH Replacement: Clinical Features and Hypothalamic–Pituitary Imaging
  47. Absence of GH-Releasing Hormone (GHRH) Mutations in Selected Patients with Isolated GH Deficiency
  48. A novel WT1 heterozygous nonsense mutation (p.K248X) causing a mild and slightly progressive nephropathy in a 46,XY patient with Denys–Drash syndrome
  49. Clinical and molecular aspects of a pediatric metachronous adrenocortical tumor
  50. Frequency of genetic polymorphisms of PXR gene in the Brazilian population
  51. Pharmacogenetics of glucocorticoid replacement could optimize the treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency
  52. 46,XY Disorders of Sex Development (46,XY DSD) due to Androgen Receptor Defects: Androgen Insensitivity Syndrome
  53. 46,XY DSD due to 17β-HSD3 Deficiency and 5α-Reductase Type 2 Deficiency
  54. MAMLD1 (Mastermind-Like Domain Containing 1) Homozygous Gain-of-Function Missense Mutation Causing 46,XX Disorder of Sex Development in a Virilized Female
  55. A novel GNAS mutation in an infant boy with pseudohypoparathyroidism type Ia and normal serum calcium and phosphate levels
  56. Novel Heterozygous NonsenseGLI2Mutations in Patients with Hypopituitarism and Ectopic Posterior Pituitary Lobe without Holoprosencephaly
  57. Male hypogonadism: childhood diagnosis and future therapies
  58. Influence of the Fibroblast Growth Factor Receptor 4 Expression and the G388R Functional Polymorphism on Cushing’s Disease Outcome
  59. Congenital Hyperinsulinism in Brazilian Neonates: A Study of Histology, KATP Channel Genes, and Proliferation of β Cells
  60. Long-Term Surgical Outcome of Masculinizing Genitoplasty in Large Cohort of Patients With Disorders of Sex Development
  61. Usefulness of MLPA in the detection of SHOX deletions
  62. The Role of <i>SRY</i> Mutations in the Etiology of Gonadal Dysgenesis in Patients with 45,X/46,XY Disorder of Sex Development and Variants
  63. Nonsense Mutations inFGF8Gene Causing Different Degrees of Human Gonadotropin-Releasing Deficiency
  64. TAC3/TACR3Mutations Reveal Preferential Activation of Gonadotropin-Releasing Hormone Release by Neurokinin B in Neonatal Life Followed by Reversal in Adulthood
  65. Nonsense Mutations inFGF8Gene Causing Different Degrees of Human Gonadotropin-Releasing Deficiency
  66. Nonsense Mutations inFGF8Gene Causing Different Degrees of Human Gonadotropin-Releasing Deficiency
  67. TAC3/TACR3Mutations Reveal Preferential Activation of GnRH Release by Neurokinin B in Neonatal Life Followed by Reversal in Adulthood
  68. TAC3/TACR3Mutations Reveal Preferential Activation of GnRH Release by Neurokinin B in Neonatal Life Followed by Reversal in Adulthood
  69. 46,XY DSD due to impaired androgen production
  70. Long-Term Surgical Outcome of Masculinizing Genitoplasty in a Large Cohort of Patients With Disorders of Sex Development (DSD)
  71. Fatigue Life Curves of NiTi Alloys – The Z Effect
  72. Steroidogenic Factor 1 Overexpression and Gene Amplification Are More Frequent in Adrenocortical Tumors from Children than from Adults
  73. Screening of autosomal gene deletions in patients with hypogonadotropic hypogonadism using multiplex ligation‐dependent probe amplification: detection of a hemizygosis for the fibroblast growth factor receptor 1
  74. ACTH-Independent Cushing’s Syndrome: Adrenocortical Tumors
  75. Kinetics of Strain Aging in Cold Rolled Low Strength Multiphase Steel
  76. Could the Leukocyte X Chromosome Inactivation Pattern Be Extrapolated to Hair Bulbs?
  77. Isolated familial somatotropinoma: 11Q13-LOH and gene/protein expression analysis suggests a possible involvement of aip also in non-pituitary tumorigenesis
  78. Effectiveness of the Combined Recombinant Human Growth Hormone and Gonadotropin-Releasing Hormone Analog Therapy in Pubertal Patients with Short Stature due toSHOXDeficiency
  79. Novel Mutations inCYP11B1Gene Leading to 11β-Hydroxylase Deficiency in Brazilian Patients
  80. Possible role of a radiation-induced p53 mutation in a Nelson’s syndrome patient with a fatal outcome
  81. MALIGNANT PHEOCHROMOCYTOMA: A STUDY OF 18 CASES
  82. Analysis of glucose-dependent insulinotropic peptide receptor (GIPR) and luteinizing hormone receptor (LHCGR) expression in human adrenocortical hyperplasia
  83. SHORT AND LONG-TERM SURGICAL OUTCOME OF MASCULINIZING GENITOPLASTY IN A LARGE COHORT OF PATIENTS WITH DISORDERS OF SEX DEVELOPMENT (DSD)
  84. ANATOMICAL AND FUNCTIONAL OUTCOME OF FEMINIZING GENITOPLASTY FOR AMBIGUOUS GENITALIA IN PATIENTS WITH VIRILIZING CONGENITAL ADRENAL HYPERPLASIA
  85. ADRENOCORTICAL CARCINOMA: A 30-YEAR EXPERIENCE AT A SINGLE INSTITUTION
  86. Comparison between weight-based and IGF-I-based growth hormone (GH) dosing in the treatment of children with GH deficiency and influence of exon 3 deleted GH receptor variant
  87. 46,XY disorders of sex development (DSD)
  88. The −202 A Allele of Insulin-Like Growth Factor Binding Protein-3 (IGFBP3) Promoter Polymorphism Is Associated with Higher IGFBP-3 Serum Levels and Better Growth Response to Growth Hormone Treatment in Patients with Severe Growth Hormone Deficiency
  89. 46,XY disorders of sex development (DSD)
  90. Noonan Syndrome and Related Disorders: A Review of Clinical Features and Mutations in Genes of the RAS/MAPK Pathway
  91. Analysis of Craniofacial and Extremity Growth in Patients with Growth Hormone Deficiency during Growth Hormone Therapy
  92. Extraadrenal 21-Hydroxylation by CYP2C19 and CYP3A4: Effect on 21-Hydroxylase Deficiency
  93. Autosomal dominant familial neurohypophyseal diabetes insipidus caused by a novel mutation in arginine-vasopressin gene in a Brazilian family
  94. Cryptic intragenic deletion of the SHOX gene in a family with Léri-Weill dyschondrosteosis detected by Multiplex Ligation-Dependent Probe Amplification (MLPA)
  95. Combined 17 alpha-hydroxylase/17,20-lyase deficiency due to a homozygous 25 BP duplication (NT 4157-4181) at exon 5 in the CYP17 resulting in a premature stop codon predicted by molecular modeling
  96. Tall stature and poor breast development after estrogen replacement in a hypergonadotrophic hypogonadic patient with a 45,X/46,X,der(X) karyotype with SHOX gene overdosage
  97. Loss-of-Function Mutations in the Genes Encoding Prokineticin-2 or Prokineticin Receptor-2 Cause Autosomal Recessive Kallmann Syndrome
  98. Effect of finishing rolling temperature on fire resistance and dynamic strain aging behavior of a structural steel
  99. Expression of Insulin-Like Growth Factor-II and Its Receptor in Pediatric and Adult Adrenocortical Tumors
  100. Analysis of the PTPN11 gene in idiopathic short stature children and Noonan syndrome patients
  101. Y-chromosomal STR haplotypes in a sample from São Paulo (Brazil)
  102. The Common P450 Oxidoreductase Variant A503V Is Not a Modifier Gene for 21-Hydroxylase Deficiency
  103. Factors Determining Normal Adult Height in Girls with Gonadotropin-Dependent Precocious Puberty Treated with Depot Gonadotropin-Releasing Hormone Analogs
  104. Baixa estatura por haploinsuficiência do gene SHOX: do diagnóstico ao tratamento
  105. Síndrome de Noonan: do fenótipo à terapêutica com hormônio de crescimento
  106. Long‐term treatment of familial male‐limited precocious puberty (testotoxicosis) with cyproterone acetate or ketoconazole
  107. Role for postoperative cortisol response to desmopressin in predicting the risk for recurrent Cushing's disease
  108. Laparoscopic Adrenalectomy for Pheocromocytoma in Children: Is It Safe?
  109. A GPR54 -Activating Mutation in a Patient with Central Precocious Puberty
  110. Update on the etiology, diagnosis and therapeutic management of sexual precocity
  111. Uma rara causa de dispnéia com apresentação singular na tomografia computadorizada de tórax: síndrome de ativação macrofágica
  112. Population and mutation analysis of Y-STR loci in a sample from the city of São Paulo (Brazil)
  113. Polymorphisms Identified in the Upstream Core Polyadenylation Signal ofIGF1Gene Exon 6 Do Not Cause Pre- and Postnatal Growth Impairment
  114. Microconversion betweenCYP21A2andCYP21A1PPromoter Regions Causes the Nonclassical Form of 21-Hydroxylase Deficiency
  115. The degree of external genitalia virilization in girls with 21‐hydroxylase deficiency appears to be influenced by the CAG repeats in the androgen receptor gene
  116. Exon 3‐deleted genotype of growth hormone receptor (GHRd3) positively influences IGF‐1 increase at generation test in children with idiopathic short stature
  117. Y‐STRs in Forensic Medicine: DNA Analysis in Semen Samples of Azoospermic Individuals
  118. Variabilidade do fenótipo de pacientes com síndrome de Noonan com e sem mutações no gene PTPN11
  119. Molecular analysis of the neuropeptide Y1 receptor gene in human idiopathic gonadotropin-dependent precocious puberty and isolated hypogonadotropic hypogonadism
  120. Classical osteoblastoma, atypical osteoblastoma, and osteosarcoma: a comparative study based on clinical, histological, and biological parameters
  121. The role of desmopressin in bilateral and simultaneous inferior petrosal sinus sampling for differential diagnosis of ACTH‐dependent Cushing's syndrome
  122. Hormonal, pituitary magnetic resonance, LHX4 and HESX1 evaluation in patients with hypopituitarism and ectopic posterior pituitary lobe
  123. Novel Fibroblast Growth Factor Receptor 1 Mutations in Patients with Congenital Hypogonadotropic Hypogonadism with and without Anosmia
  124. Effectiveness of treating ovarian hyperstimulation syndrome with cabergoline in two patients with gonadotropin-producing pituitary adenomas
  125. A single somatic activating Asp578His mutation of the luteinizing hormone receptor causes Leydig cell tumour in boys with gonadotropin‐independent precocious puberty
  126. Some aspects of the behavior of the hypothalamus–pituitary–adrenal axis in patients with uncomplicated Plasmodium falciparum malaria: Cortisol and dehydroepiandrosterone levels
  127. Anatomical and functional outcomes of feminizing genitoplasty for ambiguous genitalia in patients with virilizing congenital adrenal hyperplasia
  128. Allelic Variants of the γ-Aminobutyric Acid-A Receptor α1-Subunit Gene (GABRA1) Are Not Associated with Idiopathic Gonadotropin-Dependent Precocious Puberty in Girls with and without Electroencephalographic Abnormalities
  129. Report of a del22q11 in a patient with Mayer‐Rokitansky‐Küster‐Hauser (MRKH) anomaly and exclusion of WNT‐4, RAR‐gamma, and RXR‐alpha as major genes determining MRKH anomaly in a study of 25 affected women
  130. Growth Hormone (GH) Pharmacogenetics: Influence of GH Receptor Exon 3 Retention or Deletion on First-Year Growth Response and Final Height in Patients with Severe GH Deficiency
  131. Frequency of the allelic variant (Trp8Arg/Ile15Thr) of the luteinizing hormone gene in a Brazilian cohort of healthy subjects and in patients with hypogonadotropic hypogonadism
  132. Padronização da técnica de extração de DNA de células de mucosa oral com NaCl: aplicação no estudo do gene PROP1
  133. High Degree of Discordance Between Three-Dimensional and Two-Dimensional Lumbar Spine Bone Mineral Density in Turner's Syndrome
  134. Avanços recentes no conhecimento dos mecanismos moleculares envolvidos na tumorigênese adrenocortical
  135. PTPN11(Protein Tyrosine Phosphatase, Nonreceptor Type 11) Mutations and Response to Growth Hormone Therapy in Children with Noonan Syndrome
  136. Letter re: FSH Receptor Polymorphisms and Iatrogenic Ovarian Hyperstimulation
  137. Efeito fundador da mutação E180splice no gene do receptor de hormônio de crescimento identificada em pacientes brasileiros com insensibilidade ao GH
  138. Absence of follicle-stimulating hormone receptor activating mutations in women with iatrogenic ovarian hyperstimulation syndrome
  139. Deletion Mapping of Chromosome 17 in Benign and Malignant Adrenocortical Tumors Associated with the Arg337His Mutation of the p53 Tumor Suppressor Protein
  140. The laparoscopic management of intersex patients: the preferred approach
  141. Refining Hormonal Diagnosis of Type II 3β-Hydroxysteroid Dehydrogenase Deficiency in Patients with Premature Pubarche and Hirsutism Based on HSD3B2 Genotyping
  142. Hipoplasia das células de Leydig
  143. Craniofacial features with growth hormone treatment
  144. Síndrome de insensibilidade aos andrógenos: análise clínica, hormonal e molecular de 33 casos
  145. Insensibilidade completa aos andrógenos em pacientes brasileiras causada pela mutação P766A no gene do receptor androgênico
  146. Clinical and hormonal features of selective follicle-stimulating hormone (FSH) deficiency due to FSH beta-subunit gene mutations in both sexes
  147. Substitutions in the CYP21A2 promoter explain the simple‐virilizing form of 21‐hydroxylase deficiency in patients harbouring a P30L mutation
  148. Adrenal, supra-renal
  149. Tumores adrenocorticais: novas perspectivas
  150. Founder effect for the highly prevalent R337H mutation of tumor suppressor p53 in Brazilian patients with adrenocortical tumors
  151. Estudo multicêntrico de pacientes brasileiros com deficiência da 21-hidroxilase: correlação do genótipo com o fenótipo
  152. A Single Luteinizing Hormone Determination 2 Hours after Depot Leuprolide Is Useful for Therapy Monitoring of Gonadotropin-Dependent Precocious Puberty in Girls
  153. Complexo de Carney: relato de um caso e revisão da literatura
  154. Pituitary Apoplexy During Therapy with Cabergoline in an Adolescent Male with Prolactin-Secreting Macroadenoma
  155. A Microdeletion in the Ligand Binding Domain of Human Steroidogenic Factor 1 Causes XY Sex Reversal without Adrenal Insufficiency
  156. Mutant P450 oxidoreductase causes disordered steroidogenesis with and without Antley-Bixler syndrome
  157. Use of nonradioactive labeling to detect large gene rearrangements in 21-hydroxylase deficiency
  158. The first homozygous mutation (S226I) in the highly‐conserved WSXWS‐like motif of the GH receptor causing Laron syndrome: supression of GH secretion by GnRH analogue therapy not restored by dihydrotestosterone administration
  159. P450c17 Deficiency in Brazilian Patients: Biochemical Diagnosis through Progesterone Levels Confirmed byCYP17Genotyping
  160. Acromegalic features in growth hormore (GH)‐deficient patients after long‐term GH therapy
  161. A homozygous mutation in HESX1 is associated with evolving hypopituitarism due to impaired repressor-corepressor interaction
  162. A homozygous mutation in HESX1 is associated with evolving hypopituitarism due to impaired repressor-corepressor interaction
  163. Maternal isodisomy causing homozygosity for a dominant activating mutation of the luteinizing hormone receptor gene in a boy with familial male‐limited precocious puberty
  164. Genética molecular do eixo hipotálamo-hipófise-gonadal
  165. Familial Hyperestrogenism in Both Sexes: Clinical, Hormonal, and Molecular Studies of Two Siblings
  166. Clinical, Hormonal, Behavioral, and Genetic Characteristics of Androgen Insensitivity Syndrome in a Brazilian Cohort: Five Novel Mutations in the Androgen Receptor Gene
  167. Cushing’s Syndrome Secondary to Adrenocorticotropin-Independent Macronodular Adrenocortical Hyperplasia due to Activating Mutations ofGNAS1Gene
  168. Male Pseudohermaphroditism Due to 5α-Reductase 2 Deficiency: Outcome of a Brazilian Cohort
  169. Measurement of Dynamic Strain Aging in Pearlitic Steels by Tensile Test.
  170. GH Values after Clonidine Stimulation Measured by Immunofluorometric Assay in Normal Prepubertal Children and GH-Deficient Patients
  171. Pituitary Magnetic Resonance Imaging and Function in Patients with Growth Hormone Deficiency with and without Mutations inGHRH-R,GH-1, orPROP-1Genes
  172. Reply to correspondence from Hall—“Detection of Y‐specific sequences in patients with Turner syndrome”
  173. Three Novel Mutations in CYP21 Gene in Brazilian Patients with the Classical Form of 21-Hydroxylase Deficiency Due to a Founder Effect
  174. Aspectos Moleculares da Determinação e Diferenciação Sexual
  175. Bases Genéticas dos Distúrbios de Crescimento
  176. Population Genetics of Nine Short Tandem Repeat Loci
  177. An Unusual Phenotype of Frasier Syndrome due to IVS9 +4C>T Mutation in the WT1 Gene: Predominantly Male Ambiguous Genitalia and Absence of Gonadal Dysgenesis
  178. Female Pseudohermaphroditism Caused by a Novel Homozygous Missense Mutation of the GR Gene
  179. Poor Reproducibility of IGF-I and IGF Binding Protein-3 Generation Test in Children with Short Stature and Normal Coding Region of the GH Receptor Gene
  180. Variable ACTH-Stimulated 17-Hydroxyprogesterone Values in 21-Hydroxylase Deficiency Carriers Are Not Related to the Different CYP21 Gene Mutations
  181. Detection of Y‐specific sequences in 122 patients with Turner syndrome: Nested PCR is not a reliable method
  182. Severe and Mild Neonatal Hypothyroidism Mediate Opposite Effects on Leydig Cells of Rats
  183. Zinc supplementation does not inhibit basal and metoclopramide-stimulated prolactinemia secretion in healthy men
  184. Adrenocortical tumors: results of treatment and study of Weiss's score as a prognostic factor
  185. Telarca reversível espontaneamente em meninas pré-púberes durante o tratamento com hormônio de crescimento recombinante humano
  186. Nongenetic Male Pseudohermaphroditism and Reduced Prenatal Growth
  187. Normal bone density in male pseudohermaphroditism due to 5alpha- reductase 2 deficiency
  188. An Inherited Mutation Outside the Highly Conserved DNA-Binding Domain of the p53 Tumor Suppressor Protein in Children and Adults with Sporadic Adrenocortical Tumors
  189. Adrenocorticotropin-Dependent Precocious Puberty of Testicular Origin in a Boy with X-Linked Adrenal Hypoplasia Congenita Due to a Novel Mutation in theDAX1Gene
  190. Absence of Mutations Involving the Lim Homeobox Domain GeneLHX9in 46,XY Gonadal Agenesis and Dysgenesis
  191. Premature thelarche in girls after growth hormone therapy
  192. Laparoscopic management of intersexual states
  193. Tratamento da hiperplasia supra-renal congênita por deficiência da 21-hidroxilase
  194. 21-Hydroxylase–deficient nonclassic adrenal hyperplasia is a progressive disorder: A multicenter study
  195. Gonadotropin-Independent Precocious Puberty Due to Luteinizing Hormone Receptor Mutations in Brazilian Boys: A Novel Constitutively Activating Mutation in the First Transmembrane Helix1
  196. The effect of distinct activating mutations of the luteinizing hormone receptor gene on the pituitary–gonadal axis in both sexes
  197. No evidence of somatic activating mutations on gonadotropin receptor genes in sex cord stromal tumors
  198. Pubarca precoce: estudo retrospectivo clínico e laboratorial
  199. Male Pseudohermaphroditism due to 17β-Hydroxysteroid Dehydrogenase 3 Deficiency: Diagnosis, Psychological Evaluation, and Management
  200. Genotyping of the type II 3β-hydroxysteroid dehydrogenase gene (HSD3B2) in women with hirsutism and elevated ACTH-stimulated δ5-steroids
  201. Combined Pituitary Hormone Deficiency Caused by a Novel Mutation of a Highly Conserved Residue (F88S) in the Homeodomain of PROP-11
  202. Influence of different genotypes on 17‐hydroxyprogesterone levels in patients with nonclassical congenital adrenal hyperplasia due to 21‐hydroxylase deficiency
  203. Origin of an Ovarian Steroid Cell Tumor Causing Isosexual Pseudoprecocious Puberty Demonstrated by the Expression of Adrenal Steroidogenic Enzymes and Adrenocorticotropin Receptor
  204. Mutation analysis of the follicle-stimulating hormone receptor gene in girls with gonadotropin-independent precocious puberty resulting from autonomous cystic ovaries
  205. Clinical features of women with resistance to luteinizing hormone
  206. 17β-Hydroxysteroid Dehydrogenase-3 Deficiency: Diagnosis, Phenotypic Variability, Population Genetics, and Worldwide Distribution of Ancient andde NovoMutations1
  207. A novel point mutation (R840S) in the androgen receptor in a Brazilian family with partial androgen insensitivity syndrome
  208. A Novel Missense Mutation, GLY424SER, in Brazilian Patients with 21-Hydroxylase Deficiency1
  209. Menstrual disorders and infertility caused by inactivating mutations of the luteinizing hormone receptor gene
  210. Longitudinal Hormonal and Pituitary Imaging Changes in Two Females with Combined Pituitary Hormone Deficiency due to Deletion of A301,G302 in the PROP1 Gene1
  211. 17β-Hydroxysteroid Dehydrogenase 3 Deficiency in Women1
  212. Effect of Acute and Chronic Oral Zinc Administration in Hyperprolactinemic Patients
  213. Low Frequency of CYP21B Deletions in Brazilian Patients with Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency
  214. Molecular Genotyping in Brazilian Patients with the Classical and Nonclassical Forms of 21-Hydroxylase Deficiency1
  215. Effects of acute and chronic zinc administration on growth velocity in patients with hypopituitarism
  216. A study of patients with Nelson's syndrome
  217. The PROP1 2-Base Pair Deletion Is a Common Cause of Combined Pituitary Hormone Deficiency1
  218. No evidence of the inactivating mutation (C566T) in the follicle-stimulating hormone receptor gene in Brazilian women with premature ovarian failure
  219. Activating Mutation of the Stimulatory G Protein (gsp) as a Putative Cause of Ovarian and Testicular Human Stromal Leydig Cell Tumors1
  220. A Homozygous Microdeletion in Helix 7 of the Luteinizing Hormone Receptor Associated with Familial Testicular and Ovarian Resistance Is Due to Both Decreased Cell Surface Expression and Impaired Effector Activation by the Cell Surface Receptor
  221. Diagnostic Value of Basal and Stimulated Levels of Gonadotropins Measured By An Immunofluorometric Assay (Ifma) in the Differential Diagnosis of Precocious Puberty. 20
  222. Isosexual Pseudoprecocious Puberty By Ovarian Steroid Cell Tumor 24
  223. A Novel Homozygous Nonsense Mutation E135X in the Type II 3β-Hydroxysteroid Dehydrogenase Gene (3β-Hsd) of A Female Child With Salt-Losing Congenital Adrenal Hyperplasia (Cah). 32
  224. A novel homozygous nonsense mutation E135* in the type II 3β‐hydroxysteroid dehydrogenase gene in a girl with salt‐losing congenital adrenal hyperplasia
  225. A novel homozygous nonsense mutation E135* in the type II 3β-hydroxysteroid dehydrogenase gene in a girl with salt-losing congenital adrenal hyperplasia
  226. Apparent mineralocorticoid excess in a Brazilian kindred
  227. A Novel Nonsense Mutation in the First Zinc Finger of the Vitamin D Receptor Causing Hereditary 1,25-Dihydroxyvitamin D3-Resistant Rickets
  228. The genetic and functional basis of isolated 17,20–lyase deficiency
  229. Growth Hormone Receptor Messenger Ribonucleic Acid in Normal and Pathologic Human Adrenocortical Tissues—An Analysis by Quantitative Polymerase Chain Reaction Technique1
  230. Pheochromocytoma: Study of 50 Cases
  231. Pheochromocytoma
  232. Ovarian resistance to luteinizing hormone: A novel cause of amenorrhea and infertility
  233. Management of ambiguous genitalia in pseudohermaphrodites: New perspectives on vaginal dilation
  234. NORMAL hGH VALUES AFTER CLONIDINE STIMULATION MEASURED BY AN IMMUNOFLUOROMETRIC METHOD
  235. Brief Report
  236. THE MOLECULAR BASIS OF ISOLATED 17,20 LYASE DEFICIENCY. • 519
  237. Male Pseudohermaphroditism Due to Steroid 5α-Reductase 2 Deficiency Diagnosis, Psychological Evaluation, and Management
  238. Testicular and Ovarian Resistance to Luteinizing Hormone Caused by Inactivating Mutations of the Luteinizing Hormone–Receptor Gene
  239. Clinical, Hormonal and Pathological Findings in a Comparative Study of Adrenocortical Neoplasms in Childhood and Adulthood
  240. Clinical, Hormonal and Pathological Findings in a Comparative Study of Adrenocortical Neoplasms in Childhood and Adulthood
  241. Ectopic ACTH syndrome
  242. The essential role of zinc in growth
  243. Failure of partial hypophysectomy as definitive treatment in cushing’s disease owing to nodular corticotrope hyperpiasia; report of four cases
  244. Human androgen insensitivity due to point mutations encoding amino acid substitutions in the androgen receptor steroid-binding domain
  245. Selection of adrenal tumor cells in culture demonstrated by interphase cytogenetics
  246. Ectopic Adrenocorticotropic Hormone Syndrome
  247. Gonadal agenesis in XX and XY sisters: Evidence for the involvement of an autosomal gene
  248. Male pseudohermaphroditism caused by mutations of testicular 17β–hydroxysteroid dehydrogenase 3
  249. Natural Mutagenesis Study of the Human Steroid 5.alpha.-Reductase 2 Isoenzyme
  250. The desmopressin stimulation test in the differential diagnosis of Cushing's syndrome
  251. Macrossomia, macrocrania e incoordenação motora da infância síndrome de sotos (Mckusick 11755) estudo de 7 casos e revisão de aspectos clínicos de 198 casos publicados
  252. GAPO syndrome (McKusick 23074)—A connective tissue disorder: Report on two affected sibs and on the pathologic findings in the older
  253. Male pseudohermaphroditism due to nonsalt-losing 3β-hydroxysteroid dehydrogenase deficiency: Gender role change and absence of gynecomastia at puberty
  254. Low-dose oral clonidine: Effective growth hormone releasing agent in children but not in adolescents
  255. Spironolactone-reversible rickets associated with 11β-hydroxysteroid dehydrogenase deficiency syndrome
  256. Male pseudohermaphroditism resulting from Leydig cell hypoplasia